X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Elder Pharma with Dr. Reddys - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs DR. REDDYS LAB - Comparison Results

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA DR. REDDYS LAB ELDER PHARMA/
DR. REDDYS LAB
 
P/E (TTM) x -0.2 34.3 - View Chart
P/BV x 0.1 3.4 3.0% View Chart
Dividend Yield % 0.0 0.8 -  

Financials

 ELDER PHARMA   DR. REDDYS LAB
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
DR. REDDYS LAB
Mar-17
ELDER PHARMA/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs3803,397 11.2%   
Low Rs1882,560 7.3%   
Sales per share (Unadj.) Rs491.2856.5 57.3%  
Earnings per share (Unadj.) Rs-3.278.0 -4.1%  
Cash flow per share (Unadj.) Rs14.4139.9 10.3%  
Dividends per share (Unadj.) Rs020.00 0.0%  
Dividend yield (eoy) %00.7 0.0%  
Book value per share (Unadj.) Rs376.5739.8 50.9%  
Shares outstanding (eoy) m20.54165.74 12.4%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x0.63.5 16.6%   
Avg P/E ratio x-89.338.2 -233.7%  
P/CF ratio (eoy) x19.721.3 92.6%  
Price / Book Value ratio x0.84.0 18.7%  
Dividend payout %025.7 0.0%   
Avg Mkt Cap Rs m5,833493,632 1.2%   
No. of employees `000NA22.7 0.0%   
Total wages/salary Rs m2,17931,068 7.0%   
Avg. sales/employee Rs ThNM6,259.0-  
Avg. wages/employee Rs ThNM1,369.8-  
Avg. net profit/employee Rs ThNM569.7-  
INCOME DATA
Net Sales Rs m10,089141,961 7.1%  
Other income Rs m2571,715 15.0%   
Total revenues Rs m10,346143,676 7.2%   
Gross profit Rs m-79224,722 -3.2%  
Depreciation Rs m36110,266 3.5%   
Interest Rs m2,756634 434.7%   
Profit before tax Rs m-3,65315,537 -23.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m0349 0.0%   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m1252,965 4.2%   
Profit after tax Rs m-6512,921 -0.5%  
Gross profit margin %-7.817.4 -45.1%  
Effective tax rate %-3.419.1 -18.0%   
Net profit margin %-0.69.1 -7.1%  
BALANCE SHEET DATA
Current assets Rs m9,24096,837 9.5%   
Current liabilities Rs m9,99884,199 11.9%   
Net working cap to sales %-7.58.9 -84.4%  
Current ratio x0.91.2 80.4%  
Inventory Days Days4673 63.1%  
Debtors Days Days6098 61.4%  
Net fixed assets Rs m10,124102,552 9.9%   
Share capital Rs m206829 24.8%   
"Free" reserves Rs m5,582121,792 4.6%   
Net worth Rs m7,734122,621 6.3%   
Long term debt Rs m4,8895,449 89.7%   
Total assets Rs m22,882218,165 10.5%  
Interest coverage x-0.325.5 -1.3%   
Debt to equity ratio x0.60 1,422.6%  
Sales to assets ratio x0.40.7 67.8%   
Return on assets %11.86.2 189.3%  
Return on equity %-0.810.5 -8.0%  
Return on capital %22.312.9 173.0%  
Exports to sales %3.054.6 5.6%   
Imports to sales %0.49.4 4.6%   
Exports (fob) Rs m30777,520 0.4%   
Imports (cif) Rs m4313,274 0.3%   
Fx inflow Rs m30781,670 0.4%   
Fx outflow Rs m12526,355 0.5%   
Net fx Rs m18155,315 0.3%   
CASH FLOW
From Operations Rs m11,75421,444 54.8%  
From Investments Rs m-561-18,404 3.0%  
From Financial Activity Rs m-6,762-3,692 183.1%  
Net Cashflow Rs m4,432-1,144 -387.4%  

Share Holding

Indian Promoters % 39.6 25.5 155.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.5 5.4 138.9%  
FIIs % 16.8 35.3 47.6%  
ADR/GDR % 0.0 18.5 -  
Free float % 36.1 15.3 235.9%  
Shareholders   16,479 75,885 21.7%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   PFIZER  ABBOTT INDIA  PANACEA BIOTECH  WYETH LTD  GSK PHARMA  

Compare ELDER PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views on News

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA - STRIDES SHASUN LTD COMPARISON

COMPARE ELDER PHARMA WITH

MARKET STATS